TCTMD News http://www.tctmd.com/news/rss TCTMD News en Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests http://www.tctmd.com/news/colchicine-stabilizes-plaque-acs-patients-imaging-study-suggests <span class="field field--name-title field--type-string field--label-hidden">Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/colchicine-stabilizes-plaque-acs-patients-imaging-study-suggests"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.20.17.Colchicine%20Stabilizes%20Plaque%20in%20ACS%20Patients%2C%20Imaging%20Study%20Suggests.jpg?itok=yOEBnZPA" width="220" height="120" alt="Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 10/20/2017 - 15:18</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">While the results are “provocative,” and support inflammation’s role in CVD, colchicine’s benefits won’t be known until outcome trials are done. </div> Fri, 20 Oct 2017 19:18:11 +0000 yplata 23532 at http://www.tctmd.com TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR QoL, and More http://www.tctmd.com/news/tct-2017-high-hopes-denver-complex-pci-shorter-dapt-durations-tavr-qol-and-more <span class="field field--name-title field--type-string field--label-hidden">TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR QoL, and More </span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/tct-2017-high-hopes-denver-complex-pci-shorter-dapt-durations-tavr-qol-and-more"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.20.17.TCT%202017.High%20Hopes%20in%20Denver%20for%20Complex%20PCI%2C%20Shorter%20DAPT%20Durations%2C%20TAVR%20QoL%2C%20and%20More.jpg?itok=OtfJqtqd" width="220" height="120" alt="TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR QoL, and More " typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 10/20/2017 - 11:55</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/shelley-wood" hreflang="en">Shelley Wood</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Certain CVD treatments may reach a Rocky Mountain high, and others will be straining to touch the sun. Here’s TCTMD glimpse at this year’s lineup.</div> Fri, 20 Oct 2017 15:55:03 +0000 yplata 23531 at http://www.tctmd.com Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI http://www.tctmd.com/news/women-minorities-greater-risk-non-stent-related-events-after-pci <span class="field field--name-title field--type-string field--label-hidden">Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/women-minorities-greater-risk-non-stent-related-events-after-pci"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.20.17.Women%2C%20Minorities%20at%20Greater%20Risk%20for%20Non-Stent-Related%20Events%20After%20PCI.jpg?itok=g6YV4yZg" width="220" height="138" alt="Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 10/20/2017 - 11:21</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/yael-l-maxwell" hreflang="en">Yael L. Maxwell</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Designed to overcome representation issues in cardiology research, PLATINUM Diversity can teach lessons to future study designers, experts say.</div> Fri, 20 Oct 2017 15:21:06 +0000 yplata 23530 at http://www.tctmd.com Hurricanes and Wildfires Take Their Toll on Prominent CVD Med-Tech Companies http://www.tctmd.com/news/hurricanes-and-wildfires-take-their-toll-prominent-cvd-med-tech-companies <span class="field field--name-title field--type-string field--label-hidden">Hurricanes and Wildfires Take Their Toll on Prominent CVD Med-Tech Companies </span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/hurricanes-and-wildfires-take-their-toll-prominent-cvd-med-tech-companies"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.19.17.Hurricanes%20and%20Wildfires%20Take%20Their%20Toll%20on%20Prominent%20CVD%20Med-Tech%20Companies.jpg?itok=3cK3KLLm" width="220" height="128" alt="Hurricanes and Wildfires Take Their Toll on Prominent CVD Med-Tech Companies " typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 10/19/2017 - 16:23</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Device companies and their workers were severely affected by the natural disasters that struck Puerto Rico and California.</div> Thu, 19 Oct 2017 20:23:13 +0000 yplata 23529 at http://www.tctmd.com Evolocumab ‘Abjectly Fails’ Another Financial Stress Test http://www.tctmd.com/news/evolocumab-abjectly-fails-another-financial-stress-test <span class="field field--name-title field--type-string field--label-hidden">Evolocumab ‘Abjectly Fails’ Another Financial Stress Test</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/evolocumab-abjectly-fails-another-financial-stress-test"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.19.17.Evolocumab%20%E2%80%98Abjectly%20Fails%E2%80%99%20Another%20Financial%20Stress%20Test.jpg?itok=VFye-ajS" width="220" height="126" alt="Evolocumab ‘Abjectly Fails’ Another Financial Stress Test" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 10/19/2017 - 15:48</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">At $14,300 per year, the PCSK9 inhibitor far exceeds the currently accepted thresholds for society’s willingness to pay, according to a new study. </div> Thu, 19 Oct 2017 19:48:21 +0000 yplata 23528 at http://www.tctmd.com DOACs Not Associated With Major Bleeding, Mortality: Observational Analysis http://www.tctmd.com/news/doacs-not-associated-major-bleeding-mortality-observational-analysis <span class="field field--name-title field--type-string field--label-hidden">DOACs Not Associated With Major Bleeding, Mortality: Observational Analysis</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/doacs-not-associated-major-bleeding-mortality-observational-analysis"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.19.17.DOACs%20Not%20Associated%20With%20Major%20Bleeding%2C%20Mortality%20Observational%20Analysis.jpg?itok=B4udYJyS" width="220" height="120" alt="DOACs Not Associated With Major Bleeding, Mortality: Observational Analysis" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 10/19/2017 - 10:12</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">There is still a need for more real-world safety data, particularly in patients with chronic kidney disease treated with DOACs, say researchers. </div> Thu, 19 Oct 2017 14:12:12 +0000 yplata 23526 at http://www.tctmd.com ACC Unveils Consensus Document to Help Guide Management of Mitral Regurgitation http://www.tctmd.com/news/acc-unveils-consensus-document-help-guide-management-mitral-regurgitation <span class="field field--name-title field--type-string field--label-hidden">ACC Unveils Consensus Document to Help Guide Management of Mitral Regurgitation</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/acc-unveils-consensus-document-help-guide-management-mitral-regurgitation"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.18.17.ACC%20Unveils%20Consensus%20Document%20to%20Help%20Guide%20Management%20of%20Mitral%20Regurgitation.jpg?itok=syNeNbCF" width="220" height="129" alt="ACC Unveils Consensus Document to Help Guide Management of Mitral Regurgitation" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 10/18/2017 - 16:56</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The “guideline-enhancement document” provides more detail to assist cardiologists and others involved in treating the condition. </div> Wed, 18 Oct 2017 20:56:14 +0000 yplata 23525 at http://www.tctmd.com Lower Limb Revascularizations Increasing in PAD Patients on Dialysis http://www.tctmd.com/news/lower-limb-revascularizations-increasing-pad-patients-dialysis <span class="field field--name-title field--type-string field--label-hidden">Lower Limb Revascularizations Increasing in PAD Patients on Dialysis</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/lower-limb-revascularizations-increasing-pad-patients-dialysis"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.18.17.Lower%20Limb%20Revascularizations%20Increasing%20in%20PAD%20Patients%20on%20Dialysis.jpg?itok=uPG2W4-y" width="220" height="125" alt="Lower Limb Revascularizations Increasing in PAD Patients on Dialysis" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 10/18/2017 - 15:54</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/la-mckeown" hreflang="en">L.A. McKeown</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Nationwide data indicate that endovascular approaches are being chosen more frequently than surgery in this population.</div> Wed, 18 Oct 2017 19:54:23 +0000 yplata 23524 at http://www.tctmd.com Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria http://www.tctmd.com/news/severe-aortic-stenosis-gets-its-own-appropriate-use-criteria <span class="field field--name-title field--type-string field--label-hidden">Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/severe-aortic-stenosis-gets-its-own-appropriate-use-criteria"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.18.17.Severe%20Aortic%20Stenosis%20Gets%20Its%20Own%20Appropriate%20Use%20Criteria%20HEADER.jpg?itok=bOhN67sG" width="220" height="125" alt="Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 10/18/2017 - 14:00</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/caitlin-e-cox" hreflang="en">Caitlin E. Cox</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Joining the ranks of ACS and stable ischemic heart disease, among others, the aortic valve is getting its own list of suggested dos and don’ts.</div> Wed, 18 Oct 2017 18:00:11 +0000 yplata 23523 at http://www.tctmd.com Episode 32: COLOR - A Multicenter Registry Looking at Lipid-Rich Plaque and 2-Year Outcomes After Stenting http://www.tctmd.com/audio/episode-32-color-multicenter-registry-looking-lipid-rich-plaque-and-2-year-outcomes-after <span class="field field--name-title field--type-string field--label-hidden">Episode 32: COLOR - A Multicenter Registry Looking at Lipid-Rich Plaque and 2-Year Outcomes After Stenting</span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 10/18/2017 - 09:59</span> <div class="field field--name-field-date field--type-datetime field--label-above"> <!-- <div class="field__label">Publish Date</div> --> <div class="field__item">2 days 7 hours ago</div> </div> <div class="field field--name-field-teaser field--type-string-long field--label-above"> <!-- <div class="field__label">Teaser</div> --> <div class="field__item">Listen to C. Michael Gibson in conversation with Giora Weisz.</div> </div> Wed, 18 Oct 2017 13:59:28 +0000 yplata 23521 at http://www.tctmd.com Why All Interventionalists Should Be on Twitter http://www.tctmd.com/news/why-all-interventionalists-should-be-twitter <span class="field field--name-title field--type-string field--label-hidden">Why All Interventionalists Should Be on Twitter</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/why-all-interventionalists-should-be-twitter"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.18.17.Why%20All%20Interventionalists%20Should%20Be%20on%20Twitter.jpg?itok=efWIe126" width="220" height="126" alt="Why All Interventionalists Should Be on Twitter" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 10/18/2017 - 09:49</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/amit-k-gupta-mbbs-md" hreflang="en">Amit K. Gupta, MBBS, MD</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Twitter, a one-stop shop for collective wisdom, networking, and breaking news, can offer cardiologists a wealth of benefits, one fellow argues.</div> Wed, 18 Oct 2017 13:49:14 +0000 yplata 23520 at http://www.tctmd.com High Blood Pressure May Raise Mitral Regurgitation Risk http://www.tctmd.com/news/high-blood-pressure-may-raise-mitral-regurgitation-risk <span class="field field--name-title field--type-string field--label-hidden">High Blood Pressure May Raise Mitral Regurgitation Risk</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/high-blood-pressure-may-raise-mitral-regurgitation-risk"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.17.17.High%20Blood%20Pressure%20May%20Raise%20Mitral%20Regurgitation%20Risk_1.png?itok=f6yx6Gq-" width="220" height="136" alt="High Blood Pressure May Raise Mitral Regurgitation Risk" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Tue, 10/17/2017 - 13:41</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">“We were surprised to find such a compelling link between the two,” a researcher says.</div> Tue, 17 Oct 2017 17:41:59 +0000 yplata 23517 at http://www.tctmd.com Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond http://www.tctmd.com/news/absorb-bvs-again-linked-scaffold-thrombosis-1-year-and-beyond <span class="field field--name-title field--type-string field--label-hidden">Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/absorb-bvs-again-linked-scaffold-thrombosis-1-year-and-beyond"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.17.17.%20Absorb%20BVS%20Again%20Linked%20to%20Scaffold%20Thrombosis%20at%201%20Year%20and%20Beyond.png?itok=Xs0eBz7z" width="220" height="120" alt="Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Tue, 10/17/2017 - 11:44</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">An updated meta-analysis confirms the perils of using Absorb BVS, with investigators reporting scaffold thrombosis risks well beyond 1 year. </div> Tue, 17 Oct 2017 15:44:05 +0000 yplata 23516 at http://www.tctmd.com Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR http://www.tctmd.com/news/some-reassurances-some-sobering-truths-about-dialysis-needs-after-tavr <span class="field field--name-title field--type-string field--label-hidden">Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/some-reassurances-some-sobering-truths-about-dialysis-needs-after-tavr"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.16.17.Dialysis%20Needs%20After%20TAVR.jpg?itok=MGKEZsqj" width="220" height="125" alt="Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Mon, 10/16/2017 - 17:24</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/shelley-wood" hreflang="en">Shelley Wood</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">New insights from the STS/ACC TVT Registry may help physicians give better numbers to patients grappling with what might happen post-TAVR, experts say.</div> Mon, 16 Oct 2017 21:24:32 +0000 yplata 23514 at http://www.tctmd.com CVD Risk for Women Rises After Gestational Diabetes http://www.tctmd.com/news/cvd-risk-women-rises-after-gestational-diabetes <span class="field field--name-title field--type-string field--label-hidden">CVD Risk for Women Rises After Gestational Diabetes</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/cvd-risk-women-rises-after-gestational-diabetes"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.16.17.Gestational%20Diabetes.CVD%20Risk.jpg?itok=wmsOR7IX" width="220" height="129" alt="CVD Risk for Women Rises After Gestational Diabetes" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Mon, 10/16/2017 - 16:01</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/yael-l-maxwell" hreflang="en">Yael L. Maxwell</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Better primary prevention efforts for women who develop diabetes during pregnancy are needed, experts say.</div> Mon, 16 Oct 2017 20:01:05 +0000 yplata 23513 at http://www.tctmd.com Conference Organizers, Physicians Wary as Direct Industry Sponsorship Winds Down in Europe http://www.tctmd.com/news/conference-organizers-physicians-wary-direct-industry-sponsorship-winds-down-europe <span class="field field--name-title field--type-string field--label-hidden">Conference Organizers, Physicians Wary as Direct Industry Sponsorship Winds Down in Europe </span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/conference-organizers-physicians-wary-direct-industry-sponsorship-winds-down-europe"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.16.17.Direct%20Industry%20Sponsorship%20Winds%20Down%20in%20Europe.jpg?itok=07x8LKYq" width="220" height="128" alt="Conference Organizers, Physicians Wary as Direct Industry Sponsorship Winds Down in Europe " typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Mon, 10/16/2017 - 14:43</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">It’s too early to tell what the impact will be, but concerns remain about a potentially substantial drop-off in meeting attendance next year.</div> Mon, 16 Oct 2017 18:43:40 +0000 yplata 23512 at http://www.tctmd.com What Works, What Matters? Patient-Centered Endpoints Gain Traction in CV Clinical Trials http://www.tctmd.com/news/what-works-what-matters-patient-centered-endpoints-gain-traction-cv-clinical-trials <span class="field field--name-title field--type-string field--label-hidden">What Works, What Matters? Patient-Centered Endpoints Gain Traction in CV Clinical Trials</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/what-works-what-matters-patient-centered-endpoints-gain-traction-cv-clinical-trials"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.13.17.CV%20clinical%20trials.jpg?itok=h7S0fTbJ" width="220" height="118" alt="What Works, What Matters? Patient-Centered Endpoints Gain Traction in CV Clinical Trials" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 10/13/2017 - 14:00</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/caitlin-e-cox" hreflang="en">Caitlin E. Cox</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Advocates say study designs that incorporate patient and caregiver input could yield greater participation and a better return on investment.</div> Fri, 13 Oct 2017 18:00:55 +0000 yplata 23511 at http://www.tctmd.com Sky-High US Obesity Rates Aren’t Coming Down http://www.tctmd.com/news/sky-high-us-obesity-rates-arent-coming-down <span class="field field--name-title field--type-string field--label-hidden">Sky-High US Obesity Rates Aren’t Coming Down</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/sky-high-us-obesity-rates-arent-coming-down"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.13.17.US%20Obesity%20Rates%20Aren%E2%80%99t%20Coming%20Down.jpg?itok=fKE7Uj38" width="220" height="123" alt="Sky-High US Obesity Rates Aren’t Coming Down" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 10/13/2017 - 12:58</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Nearly 40% of adults and 19% of children and teens are obese, according to the most recent NHANES data.</div> Fri, 13 Oct 2017 16:58:08 +0000 yplata 23510 at http://www.tctmd.com Complications Spiked, Then Fell, After Initial Introduction of Watchman LAA Closure Device http://www.tctmd.com/news/complications-spiked-then-fell-after-initial-introduction-watchman-laa-closure-device <span class="field field--name-title field--type-string field--label-hidden">Complications Spiked, Then Fell, After Initial Introduction of Watchman LAA Closure Device</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/complications-spiked-then-fell-after-initial-introduction-watchman-laa-closure-device"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/Watchman%20updated_0.jpg?itok=bmoVIl39" width="220" height="138" alt="Complications Spiked, Then Fell, After Initial Introduction of Watchman LAA Closure Device" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 10/12/2017 - 16:54</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">All device manufacturers need to focus on a tightly controlled rollout when moving from clinical trials to real-world use, a researcher says.</div> Thu, 12 Oct 2017 20:54:42 +0000 yplata 23509 at http://www.tctmd.com Multiarterial CABG Gets a Boost in Retrospective Analysis http://www.tctmd.com/news/multiarterial-cabg-gets-boost-retrospective-analysis <span class="field field--name-title field--type-string field--label-hidden">Multiarterial CABG Gets a Boost in Retrospective Analysis </span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/multiarterial-cabg-gets-boost-retrospective-analysis"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.12.17.Multiarterial%20CABG.jpg?itok=i-iKsYTh" width="220" height="121" alt="Multiarterial CABG Gets a Boost in Retrospective Analysis " typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 10/12/2017 - 15:52</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/yael-l-maxwell" hreflang="en">Yael L. Maxwell</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The results back up what many surgeons already believe, but certain differences between the cohorts are a substantial limitation, an expert says. </div> Thu, 12 Oct 2017 19:52:51 +0000 yplata 23508 at http://www.tctmd.com Merck Calls Quits on CETP Inhibitor Anacetrapib http://www.tctmd.com/news/merck-calls-quits-cetp-inhibitor-anacetrapib <span class="field field--name-title field--type-string field--label-hidden">Merck Calls Quits on CETP Inhibitor Anacetrapib </span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/merck-calls-quits-cetp-inhibitor-anacetrapib"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.13.17.Merck_.%20CETP%20Inhibitor%20Anacetrapib.jpg?itok=J5M45F8l" width="220" height="126" alt="Merck Calls Quits on CETP Inhibitor Anacetrapib " typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 10/12/2017 - 11:04</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Although the drug modestly succeeded in REVEAL, company execs deemed the benefit insufficient to justify the pursuit of regulatory approval. </div> Thu, 12 Oct 2017 15:04:39 +0000 yplata 23507 at http://www.tctmd.com Female Surgeons Hold Slight Edge Over Male Peers in Terms of Patients’ 30-Day Mortality http://www.tctmd.com/news/female-surgeons-hold-slight-edge-over-male-peers-terms-patients-30-day-mortality <span class="field field--name-title field--type-string field--label-hidden">Female Surgeons Hold Slight Edge Over Male Peers in Terms of Patients’ 30-Day Mortality</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/female-surgeons-hold-slight-edge-over-male-peers-terms-patients-30-day-mortality"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.11.17.%20Female%20Surgeons%20Hold%20Slight%20Edge%20Over%20Male%20Peers.jpg?itok=Dv6NqkuY" width="220" height="131" alt="Female Surgeons Hold Slight Edge Over Male Peers in Terms of Patients’ 30-Day Mortality" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 10/11/2017 - 16:27</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/caitlin-e-cox" hreflang="en">Caitlin E. Cox</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">That results were largely similar for both sexes could inform discussions on diversity in a field traditionally dominated by men, researchers say.</div> Wed, 11 Oct 2017 20:27:18 +0000 yplata 23506 at http://www.tctmd.com Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force http://www.tctmd.com/news/bioresorbable-scaffolds-not-be-chosen-over-des-says-european-task-force <span class="field field--name-title field--type-string field--label-hidden">Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/bioresorbable-scaffolds-not-be-chosen-over-des-says-european-task-force"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.11.17.Bioresorbable%20Scaffolds%20Over%20DES.jpg?itok=oRhmX-mc" width="220" height="125" alt="Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 10/11/2017 - 14:20</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Although there are four approved BRS devices in Europe, experts say current-generation DES are the preferred choice in PCI. </div> Wed, 11 Oct 2017 18:20:34 +0000 yplata 23505 at http://www.tctmd.com Be a HOT Interventionalist With Honest, Open, Two-Way Communication http://www.tctmd.com/news/be-hot-interventionalist-honest-open-two-way-communication <span class="field field--name-title field--type-string field--label-hidden">Be a HOT Interventionalist With Honest, Open, Two-Way Communication</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/be-hot-interventionalist-honest-open-two-way-communication"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.11.17.optimal%20communication%20practices%20for%20their%20future%20patients.jpg?itok=Cm27rPZf" width="220" height="123" alt="Be a HOT Interventionalist With Honest, Open, Two-Way Communication" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 10/11/2017 - 11:22</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/kimberly-atianzar-md" hreflang="en">Kimberly Atianzar, MD</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Fellows are perhaps in the best position to learn optimal communication practices for their future patients.</div> Wed, 11 Oct 2017 15:22:39 +0000 yplata 23503 at http://www.tctmd.com Episode 18: Top News of TCT 2016 Plus Anticoagulation in A-fib Patients http://www.tctmd.com/audio/episode-18-top-news-tct-2016-plus-anticoagulation-fib-patients <span class="field field--name-title field--type-string field--label-hidden">Episode 18: Top News of TCT 2016 Plus Anticoagulation in A-fib Patients</span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 10/11/2017 - 10:09</span> <div class="field field--name-field-date field--type-datetime field--label-above"> <!-- <div class="field__label">Publish Date</div> --> <div class="field__item">1 week 2 days ago</div> </div> <div class="field field--name-field-teaser field--type-string-long field--label-above"> <!-- <div class="field__label">Teaser</div> --> <div class="field__item">Today&#039;s episode is hosted by Roxana Mehran and features guests Susheel Kodali, Sean Salmon, Pieter Smits, Molly Szerlip, Giora Weisz, and Shelley Wood.</div> </div> Wed, 11 Oct 2017 14:09:39 +0000 yplata 23502 at http://www.tctmd.com Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR http://www.tctmd.com/news/excluded-trials-patients-severe-kidney-disease-benefit-less-tavr <span class="field field--name-title field--type-string field--label-hidden">Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/excluded-trials-patients-severe-kidney-disease-benefit-less-tavr"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.10.17.Severe%20Kidney%20Disease%20Benefit%20Less%20From%20TAVR.jpg?itok=dlUGSObq" width="220" height="123" alt="Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Tue, 10/10/2017 - 17:09</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/shelley-wood" hreflang="en">Shelley Wood</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Chronic and end-stage-disease patients have more complications and lower survival than those with normal renal function, registry data show.</div> Tue, 10 Oct 2017 21:09:57 +0000 yplata 23500 at http://www.tctmd.com Alirocumab Ban Reversed, New Trial Ordered in PCSK9 Patent Dispute http://www.tctmd.com/news/alirocumab-ban-reversed-new-trial-ordered-pcsk9-patent-dispute <span class="field field--name-title field--type-string field--label-hidden">Alirocumab Ban Reversed, New Trial Ordered in PCSK9 Patent Dispute </span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/alirocumab-ban-reversed-new-trial-ordered-pcsk9-patent-dispute"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.10.17.alirocumab.PCSK9%20Patent%20Dispute.jpg?itok=HwJf5V_m" width="220" height="117" alt="Alirocumab Ban Reversed, New Trial Ordered in PCSK9 Patent Dispute " typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Tue, 10/10/2017 - 17:03</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The decision is a win for Sanofi/Regeneron, which have been battling with Amgen over patents related to the pricey PCSK9 inhibitors. </div> Tue, 10 Oct 2017 21:03:59 +0000 yplata 23499 at http://www.tctmd.com Atrial Fibrillation in Obese Patients a Growing Concern, Experts Say http://www.tctmd.com/news/atrial-fibrillation-obese-patients-growing-concern-experts-say <span class="field field--name-title field--type-string field--label-hidden">Atrial Fibrillation in Obese Patients a Growing Concern, Experts Say</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/atrial-fibrillation-obese-patients-growing-concern-experts-say"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.10.17.Atrial%20Fibrillation%20in%20Obese%20Patients%20a%20Growing%20Concern%2C%20Experts%20Say.jpg?itok=oQpSnxlh" width="220" height="132" alt="Atrial Fibrillation in Obese Patients a Growing Concern, Experts Say" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Tue, 10/10/2017 - 10:25</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/caitlin-e-cox" hreflang="en">Caitlin E. Cox</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Patients with excess body weight are more likely to develop A-fib, but when they do they have a better prognosis than their leaner peers.</div> Tue, 10 Oct 2017 14:25:05 +0000 yplata 23498 at http://www.tctmd.com Same-Day Discharge After PAD Procedures Safe in Elderly Patients http://www.tctmd.com/news/same-day-discharge-after-pad-procedures-safe-elderly-patients <span class="field field--name-title field--type-string field--label-hidden">Same-Day Discharge After PAD Procedures Safe in Elderly Patients</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/same-day-discharge-after-pad-procedures-safe-elderly-patients"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.9.17.Same-Day%20Discharge%20After%20PAD%20Procedures%20Safe%20in%20Elderly%20Patients.jpg?itok=vbvpAItL" width="220" height="127" alt="Same-Day Discharge After PAD Procedures Safe in Elderly Patients" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Mon, 10/09/2017 - 14:37</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/la-mckeown" hreflang="en">L.A. McKeown</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Compared with younger patients, those over age 70 had no increases in complications or need for hospitalization.</div> Mon, 09 Oct 2017 18:37:44 +0000 yplata 23495 at http://www.tctmd.com Rivaroxaban Trial in Patients With Embolic Stroke of Undetermined Source Stopped Early http://www.tctmd.com/news/rivaroxaban-trial-patients-embolic-stroke-undetermined-source-stopped-early <span class="field field--name-title field--type-string field--label-hidden">Rivaroxaban Trial in Patients With Embolic Stroke of Undetermined Source Stopped Early</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/rivaroxaban-trial-patients-embolic-stroke-undetermined-source-stopped-early"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.09.17.Rivaroxaban%20Trial%20in%20Patients%20With%20Embolic%20Stroke%20of%20Undetermined%20Source%20Stopped%20Early.jpg?itok=AHJVEvsd" width="220" height="125" alt="Rivaroxaban Trial in Patients With Embolic Stroke of Undetermined Source Stopped Early" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Mon, 10/09/2017 - 14:31</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">An interim analysis of NAVIGATE ESUS showed the NOAC was no more effective than low-dose aspirin and increased major bleeding.</div> Mon, 09 Oct 2017 18:31:13 +0000 yplata 23494 at http://www.tctmd.com High-Sensitivity Troponin Tests Still Useful in Patients With Renal Dysfunction and Suspected ACS, With Caveats http://www.tctmd.com/news/high-sensitivity-troponin-tests-still-useful-patients-renal-dysfunction-and-suspected-acs <span class="field field--name-title field--type-string field--label-hidden">High-Sensitivity Troponin Tests Still Useful in Patients With Renal Dysfunction and Suspected ACS, With Caveats </span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/high-sensitivity-troponin-tests-still-useful-patients-renal-dysfunction-and-suspected-acs"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.6.17.troponin.High-Sensitivity%20Troponin%20Tests%20Still%20Useful%20in%20Patients%20With%20Renal%20Dysfunction%20and%20Suspected%20ACS%2C%20With%20Caveats.jpg?itok=dIWMph81" width="220" height="126" alt="High-Sensitivity Troponin Tests Still Useful in Patients With Renal Dysfunction and Suspected ACS, With Caveats " typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 10/06/2017 - 16:58</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/yael-l-maxwell" hreflang="en">Yael L. Maxwell</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">New research should help physicians “understand the nuances” of test results in the setting of chronic kidney disease, experts say.</div> Fri, 06 Oct 2017 20:58:54 +0000 yplata 23493 at http://www.tctmd.com NOAC Bleeding Risk Rises With Several Drug Combinations http://www.tctmd.com/news/noac-bleeding-risk-rises-several-drug-combinations <span class="field field--name-title field--type-string field--label-hidden">NOAC Bleeding Risk Rises With Several Drug Combinations </span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/noac-bleeding-risk-rises-several-drug-combinations"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.6.17.%20NOAC%20Bleeding%20Risk%20Rises%20With%20Several%20Drug%20Combinations.jpg?itok=8kMlazDw" width="220" height="117" alt="NOAC Bleeding Risk Rises With Several Drug Combinations " typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 10/06/2017 - 15:40</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Pairing NOACs with amiodarone and fluconazole increased the risk of major bleeding, while adding atorvastatin lessened the risk. </div> Fri, 06 Oct 2017 19:40:30 +0000 yplata 23491 at http://www.tctmd.com Same-Same but Different? Noninferiority Trials Need a Revamp, NEJM Review Argues http://www.tctmd.com/news/same-same-different-noninferiority-trials-need-revamp-nejm-review-argues <span class="field field--name-title field--type-string field--label-hidden">Same-Same but Different? Noninferiority Trials Need a Revamp, NEJM Review Argues </span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/same-same-different-noninferiority-trials-need-revamp-nejm-review-argues"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.6.17.Same-Same%20but%20Different.%20Noninferiority%20Trials%20Need%20a%20Revamp%2C%20NEJM%20Review%20Argues.jpg?itok=Msu3fBBS" width="220" height="120" alt="Same-Same but Different? Noninferiority Trials Need a Revamp, NEJM Review Argues " typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 10/06/2017 - 12:40</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/caitlin-e-cox" hreflang="en">Caitlin E. Cox</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">In these types of studies, new therapies must prove they are no worse than their predecessors and also offer something unique, experts say.</div> Fri, 06 Oct 2017 16:40:29 +0000 yplata 23490 at http://www.tctmd.com CTA Reduces MI Compared With Functional Stress Testing, but at a Cost http://www.tctmd.com/news/cta-reduces-mi-compared-functional-stress-testing-cost <span class="field field--name-title field--type-string field--label-hidden">CTA Reduces MI Compared With Functional Stress Testing, but at a Cost</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/cta-reduces-mi-compared-functional-stress-testing-cost"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/CCTA.updated.jpg?itok=hR2Xry2Q" width="220" height="114" alt="CTA Reduces MI Compared With Functional Stress Testing, but at a Cost" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 10/05/2017 - 16:36</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Researchers argue that even the MI benefit is debatable, emphasizing the increased use of downstream invasive procedures with CTA. </div> Thu, 05 Oct 2017 20:36:05 +0000 yplata 23489 at http://www.tctmd.com Asymptomatic Carotid Artery Stenosis: When to Screen and When to Intervene http://www.tctmd.com/news/asymptomatic-carotid-artery-stenosis-when-screen-and-when-intervene <span class="field field--name-title field--type-string field--label-hidden">Asymptomatic Carotid Artery Stenosis: When to Screen and When to Intervene</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/asymptomatic-carotid-artery-stenosis-when-screen-and-when-intervene"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.5.17.Asymptomatic%20Carotid%20Artery%20Stenosis%20When%20to%20Screen%20and%20When%20to%20Intervene.jpg?itok=y2A8yUB6" width="220" height="130" alt="Asymptomatic Carotid Artery Stenosis: When to Screen and When to Intervene" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 10/05/2017 - 13:37</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Patients weighing an intervention to reduce stroke risk should consider enrolling in the ongoing CREST-2 trial, two experts agree.</div> Thu, 05 Oct 2017 17:37:59 +0000 yplata 23487 at http://www.tctmd.com Generic ARBs Linked to Increased Adverse Events http://www.tctmd.com/news/generic-arbs-linked-increased-adverse-events <span class="field field--name-title field--type-string field--label-hidden">Generic ARBs Linked to Increased Adverse Events</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/generic-arbs-linked-increased-adverse-events"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.4.17.Generic%20ARBs%20Linked%20to%20Increased%20Adverse%20Events.jpg?itok=w9Rxe-Nl" width="220" height="124" alt="Generic ARBs Linked to Increased Adverse Events" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 10/04/2017 - 14:48</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">When the generic medications made it to market, investigators saw a spike in hospitalizations and ER consultations in the first month. </div> Wed, 04 Oct 2017 18:48:35 +0000 yplata 23486 at http://www.tctmd.com Vast Majority Return to Work After MI, but It Doesn’t Always Stick http://www.tctmd.com/news/vast-majority-return-work-after-mi-it-doesnt-always-stick <span class="field field--name-title field--type-string field--label-hidden">Vast Majority Return to Work After MI, but It Doesn’t Always Stick</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/vast-majority-return-work-after-mi-it-doesnt-always-stick"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.4.17.Image_.Vast%20Majority%20Return%20to%20Work%20After%20MI%2C%20but%20It%20Doesn%E2%80%99t%20Always%20Stick.jpg?itok=IdOvWBy4" width="220" height="122" alt="Vast Majority Return to Work After MI, but It Doesn’t Always Stick" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 10/04/2017 - 13:11</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Roughly one-quarter of those who go back to work subsequently leave employment and begin receiving social benefits.</div> Wed, 04 Oct 2017 17:11:46 +0000 yplata 23485 at http://www.tctmd.com Episode 31: PLATINUM DIVERSITY - Outcomes With Coronary Stenting in Women and Minorities http://www.tctmd.com/audio/episode-31-platinum-diversity-outcomes-coronary-stenting-women-and-minorities <span class="field field--name-title field--type-string field--label-hidden">Episode 31: PLATINUM DIVERSITY - Outcomes With Coronary Stenting in Women and Minorities</span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 10/04/2017 - 11:12</span> <div class="field field--name-field-date field--type-datetime field--label-above"> <!-- <div class="field__label">Publish Date</div> --> <div class="field__item">2 weeks 2 days ago</div> </div> <div class="field field--name-field-teaser field--type-string-long field--label-above"> <!-- <div class="field__label">Teaser</div> --> <div class="field__item">C. Michael Gibson reviews new registry results with Wayne Batchelor.</div> </div> Wed, 04 Oct 2017 15:12:49 +0000 yplata 23484 at http://www.tctmd.com Switching to E-Cigarettes From Tobacco Could Drastically Curb Premature Death http://www.tctmd.com/news/switching-e-cigarettes-tobacco-could-drastically-curb-premature-death <span class="field field--name-title field--type-string field--label-hidden">Switching to E-Cigarettes From Tobacco Could Drastically Curb Premature Death</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/switching-e-cigarettes-tobacco-could-drastically-curb-premature-death"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.4.17.Switching%20to%20E-Cigarettes%20From%20Tobacco%20Could%20Drastically%20Curb%20Premature%20Death.jpg?itok=xXcB8FvC" width="220" height="118" alt="Switching to E-Cigarettes From Tobacco Could Drastically Curb Premature Death" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 10/04/2017 - 09:50</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/caitlin-e-cox" hreflang="en">Caitlin E. Cox</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">If 95% of US smokers made the change over a 10-year period, 6.6 million lives might be saved by the year 2100, researchers suggest.</div> Wed, 04 Oct 2017 13:50:55 +0000 yplata 23483 at http://www.tctmd.com Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI http://www.tctmd.com/news/bleeding-and-ischemic-events-fluctuate-out-1-year-post-stemi-horizons-ami <span class="field field--name-title field--type-string field--label-hidden">Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/bleeding-and-ischemic-events-fluctuate-out-1-year-post-stemi-horizons-ami"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.3.17.Image_.Bleeding%20and%20Ischemic%20Events%20Fluctuate%20Out%20to%201%20Year%20Post-STEMI.jpg?itok=t1vjBEQh" width="220" height="119" alt="Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Tue, 10/03/2017 - 12:52</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/yael-l-maxwell" hreflang="en">Yael L. Maxwell</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The results support the use of potent platelet inhibition for 1 year after primary PCI, authors and experts say.</div> Tue, 03 Oct 2017 16:52:28 +0000 yplata 23482 at http://www.tctmd.com Modified Risk Score for ED Chest Pain Patients Reduces Hospital Stays, Lowers Costs http://www.tctmd.com/news/modified-risk-score-ed-chest-pain-patients-reduces-hospital-stays-lowers-costs <span class="field field--name-title field--type-string field--label-hidden">Modified Risk Score for ED Chest Pain Patients Reduces Hospital Stays, Lowers Costs </span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/modified-risk-score-ed-chest-pain-patients-reduces-hospital-stays-lowers-costs"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/10.3.17.Modified%20Risk%20Score%20for%20ED%20Chest%20Pain%20Patients.jpg?itok=IOQR6Tnm" width="220" height="128" alt="Modified Risk Score for ED Chest Pain Patients Reduces Hospital Stays, Lowers Costs " typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Tue, 10/03/2017 - 10:25</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The score could save the healthcare system billions of dollars by avoiding needless stress testing in low-risk patients, says researcher. </div> Tue, 03 Oct 2017 14:25:57 +0000 yplata 23480 at http://www.tctmd.com FDA Warns of Rising Endoleak Rates After Endovascular Aneurysm Repair http://www.tctmd.com/news/fda-warns-rising-endoleak-rates-after-endovascular-aneurysm-repair <span class="field field--name-title field--type-string field--label-hidden">FDA Warns of Rising Endoleak Rates After Endovascular Aneurysm Repair</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/fda-warns-rising-endoleak-rates-after-endovascular-aneurysm-repair"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/EVAR.endoleak.rate_.header.jpg?itok=pkMmpATr" width="220" height="128" alt="FDA Warns of Rising Endoleak Rates After Endovascular Aneurysm Repair" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Mon, 10/02/2017 - 16:17</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/la-mckeown" hreflang="en">L.A. McKeown</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">A letter sent last week is cautioning healthcare providers to watch out for type III endoleaks after EVAR, following an uptick in reports. </div> Mon, 02 Oct 2017 20:17:18 +0000 yplata 23479 at http://www.tctmd.com ‘A Healthy Brexit’? How a Split From EU Could Affect UK Health System http://www.tctmd.com/news/healthy-brexit-how-split-eu-could-affect-uk-health-system <span class="field field--name-title field--type-string field--label-hidden">‘A Healthy Brexit’? How a Split From EU Could Affect UK Health System</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/healthy-brexit-how-split-eu-could-affect-uk-health-system"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/UK.header.jpg?itok=aTjCeEta" width="220" height="126" alt="‘A Healthy Brexit’? How a Split From EU Could Affect UK Health System" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Mon, 10/02/2017 - 11:33</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/yael-l-maxwell" hreflang="en">Yael L. Maxwell</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">When the UK leaves the EU, there are likely to be far more consequences than opportunities for its health system, some predict.</div> Mon, 02 Oct 2017 15:33:45 +0000 yplata 23476 at http://www.tctmd.com Impella Has Some Benefits in High-Risk PCI, but Clinical Impact Still Uncertain: Review http://www.tctmd.com/news/impella-has-some-benefits-high-risk-pci-clinical-impact-still-uncertain-review <span class="field field--name-title field--type-string field--label-hidden">Impella Has Some Benefits in High-Risk PCI, but Clinical Impact Still Uncertain: Review</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/impella-has-some-benefits-high-risk-pci-clinical-impact-still-uncertain-review"><img src="/sites/default/files/efs/public/styles/medium/public/2017-10/emergency.header.jpg?itok=zJ_0L55a" width="220" height="123" alt="Impella Has Some Benefits in High-Risk PCI, but Clinical Impact Still Uncertain: Review" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Mon, 10/02/2017 - 11:06</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Large RCTs are needed to provide definitive evidence of the safety and effectiveness of Impella in high-risk PCI, the authors say.</div> Mon, 02 Oct 2017 15:06:13 +0000 yplata 23475 at http://www.tctmd.com TCTMD’s Top 10 Most Popular Stories for September 2017 http://www.tctmd.com/news/tctmds-top-10-most-popular-stories-september-2017 <span class="field field--name-title field--type-string field--label-hidden">TCTMD’s Top 10 Most Popular Stories for September 2017</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/tctmds-top-10-most-popular-stories-september-2017"><img src="/sites/default/files/efs/public/styles/medium/public/2017-09/2.7.17.top10.image_.creative.header.jpg?itok=3WGOJoF_" width="220" height="107" alt="TCTMD’s Top 10 Most Popular Stories for September 2017" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 09/29/2017 - 15:37</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/shelley-wood" hreflang="en">Shelley Wood</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">ESC carryovers, NOACs at VIVA, and feature stories reacting to COMPASS and Absorb’s disappearance were among our most popular news this month.</div> Fri, 29 Sep 2017 19:37:11 +0000 yplata 23474 at http://www.tctmd.com Women Receive Less Aggressive CABG Compared With Men http://www.tctmd.com/news/women-receive-less-aggressive-cabg-compared-men <span class="field field--name-title field--type-string field--label-hidden">Women Receive Less Aggressive CABG Compared With Men</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/women-receive-less-aggressive-cabg-compared-men"><img src="/sites/default/files/efs/public/styles/medium/public/2017-09/9.29.17.CABG_.old_.patient.jpg?itok=UjYHTKdK" width="220" height="117" alt="Women Receive Less Aggressive CABG Compared With Men" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 09/29/2017 - 14:44</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/yael-l-maxwell" hreflang="en">Yael L. Maxwell</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Retrospective data show progress, but more improvement can come by increasing “diagnostic suspicion” for female patients, senior author says.</div> Fri, 29 Sep 2017 18:44:26 +0000 yplata 23472 at http://www.tctmd.com No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib http://www.tctmd.com/news/no-anticoagulation-benefit-high-bleeding-risk-seen-patients-secondary-fib <span class="field field--name-title field--type-string field--label-hidden">No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/no-anticoagulation-benefit-high-bleeding-risk-seen-patients-secondary-fib"><img src="/sites/default/files/efs/public/styles/medium/public/2017-09/9.29.17.question.mark_.jpg?itok=2_jd7Srp" width="220" height="109" alt="No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 09/29/2017 - 14:35</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Investigators question whether secondary A-fib patients get the same anticoagulation benefits seen in other A-fib patients. </div> Fri, 29 Sep 2017 18:35:45 +0000 yplata 23471 at http://www.tctmd.com Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis http://www.tctmd.com/news/hemodynamics-first-gen-sapien-valve-hold-well-over-years-partner-analysis <span class="field field--name-title field--type-string field--label-hidden">Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/hemodynamics-first-gen-sapien-valve-hold-well-over-years-partner-analysis"><img src="/sites/default/files/efs/public/styles/medium/public/2017-09/clock.header.jpg?itok=H3Q4DX9A" width="220" height="136" alt="Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 09/29/2017 - 12:30</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/caitlin-e-cox" hreflang="en">Caitlin E. Cox</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Although the study “is encouraging and reassuring, it must be considered only a starting point and not a definitive answer,” experts say.</div> Fri, 29 Sep 2017 16:30:01 +0000 yplata 23470 at http://www.tctmd.com CT Scans Before and After TAVR Show Tricuspid, Bicuspid Valves Are Reassuringly Similar http://www.tctmd.com/news/ct-scans-and-after-tavr-show-tricuspid-bicuspid-valves-are-reassuringly-similar <span class="field field--name-title field--type-string field--label-hidden">CT Scans Before and After TAVR Show Tricuspid, Bicuspid Valves Are Reassuringly Similar</span> <div class="field field--name-field-header-image field--type-image field--label-hidden field__item"> <a href="/news/ct-scans-and-after-tavr-show-tricuspid-bicuspid-valves-are-reassuringly-similar"><img src="/sites/default/files/efs/public/styles/medium/public/2017-09/TAVR.device.CT_.aortic.valve_.jpg?itok=flIlN2cn" width="220" height="105" alt="CT Scans Before and After TAVR Show Tricuspid, Bicuspid Valves Are Reassuringly Similar" typeof="foaf:Image" class="image-style-medium" /> </a> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 09/28/2017 - 17:00</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/shelley-wood" hreflang="en">Shelley Wood</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">A new imaging study hints that type 1 bicuspid disease is similar to tricuspid aortic stenosis in important and unexpected ways. </div> Thu, 28 Sep 2017 21:00:14 +0000 yplata 23467 at http://www.tctmd.com Featured Fellow: Felipe Albuquerque, MD http://www.tctmd.com/news/featured-fellow-felipe-albuquerque-md <span class="field field--name-title field--type-string field--label-hidden">Featured Fellow: Felipe Albuquerque, MD</span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13825" typeof="schema:Person" property="schema:name" datatype="">yplata</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 09/28/2017 - 14:50</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/yael-l-maxwell" hreflang="en">Yael L. Maxwell</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Following in the footsteps of his cardiologist father, one fellow aims to make his mark on the field of structural interventions.</div> Thu, 28 Sep 2017 18:50:28 +0000 yplata 23466 at http://www.tctmd.com